130 related articles for article (PubMed ID: 1375431)
1. Cutaneous T-cell lymphoma presenting with diffuse lymphomatous infiltration of the peripheral nerves: response to combination chemotherapy.
Atiq OT; DeAngelis LM; Rosenblum M; Portlock CS
Am J Clin Oncol; 1992 Jun; 15(3):212-5. PubMed ID: 1375431
[TBL] [Abstract][Full Text] [Related]
2. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
[No Abstract] [Full Text] [Related]
3. Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Fierro MT; Doveil GC; Quaglino P; Savoia P; Verrone A; Bernengo MG
Dermatology; 1997; 194(3):268-72. PubMed ID: 9187846
[TBL] [Abstract][Full Text] [Related]
4. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
5. Cutaneous T-cell lymphoma presenting as facial swelling: report of a case and review of the literature.
Thomas DW; Lewis MA; Cowpe JG
Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):356-8. PubMed ID: 7699274
[TBL] [Abstract][Full Text] [Related]
6. Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Chen CC; Teng CL; Yeh SP
Ann Hematol; 2016 Apr; 95(5):837-40. PubMed ID: 26873089
[No Abstract] [Full Text] [Related]
7. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
8. [Analytical study of 13 cases of cutaneous lymphoma].
Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
[No Abstract] [Full Text] [Related]
9. Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.
Natazuka T; Matsui T; Ito M; Sugimoto T; Nakao Y; Fujita T
Leuk Res; 1992; 16(4):417-8. PubMed ID: 1373460
[No Abstract] [Full Text] [Related]
10. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
[No Abstract] [Full Text] [Related]
11. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
[No Abstract] [Full Text] [Related]
12. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
[TBL] [Abstract][Full Text] [Related]
13. T-zone lymphoma with cutaneous involvement: a case report and review of the literature.
Kazakov DV; Kempf W; Michaelis S; Schmid U; Cogliatti S; Dummer R; Burg G
Br J Dermatol; 2002 Jun; 146(6):1096-100. PubMed ID: 12072087
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
Li Y; Li Z; Lin HL; Chen XH; Li B
Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Zinzani PL; Stefoni V; Alinari L; Vianelli N; Baccarani M
Leuk Lymphoma; 2003 Sep; 44(9):1637-8. PubMed ID: 14565673
[No Abstract] [Full Text] [Related]
16. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
[TBL] [Abstract][Full Text] [Related]
17. ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.
Mebazaa A; Dupuy A; Rybojad M; Mouly F; Moulonguet I; Vignon-Pennamen MD; Rivet J; Janin A; Lebbé C; Dubertret L; Morel P; Bachelez H; Brice P
Hematol J; 2005; 5(7):553-8. PubMed ID: 15692599
[TBL] [Abstract][Full Text] [Related]
18. Nodal peripheral T-cell lymphoma with secondary granulomatous cutaneous involvement.
Marzano AV; Vanotti M; Boneschi V; Gianelli U; Alessi E
Acta Derm Venereol; 2004; 84(4):325-7. PubMed ID: 15339087
[No Abstract] [Full Text] [Related]
19. Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
Longo DL; Duffey PL; Jaffe ES; Raffeld M; Hubbard SM; Fisher RI; Wittes RE; DeVita VT; Young RC
J Clin Oncol; 1994 Oct; 12(10):2153-9. PubMed ID: 7523607
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
